Agomelatine vs placebo
Adverse events as N of participants with at least one adverse event subjective and objective · adults with a history of SAD
It is very uncertain whether agomelatine changes number of persons with at least one adverse event within a year compared with placebo (very low certainty).
1 finding from 1 review
- Melatonin and agomelatine for preventing seasonal affective disorder 2019 · Cochrane Headline outcomes onlyRR 1.06 [0.84, 1.34]1 study · 225 participantsVery low